Research Roundup: Sept 23, 2025
- Lex Pelger
- Sep 23
- 2 min read
Best of cannabinoid science this week...
For people with degenerative spine & joint diseases, cannabis helped with pain
Cannabis therapy for pain management in degenerative diseases – implementation of R&D results in health resort. A case study and best practices
For the mental health uses of cannabis, a survey of older Canadians found the majority thought cannabis somewhat or extremely helpful in managing their symptoms
Characterization of the Use and Perceptions of Cannabis for Mental Health in Older Canadians: A Cross-Sectional Analysis
In children with treatment-resistant epilepsies, CBD reduced their seizures & improved other symptoms with a strong retention rate over 18 months
Assessing Real World Efficacy, Safety, and 18‐Month Retention Rates of Cannabidiol in Individuals With Drug Resistant Epilepsies
In children with drug-resistant epilepsy taking Epidyolex (pharmaceutical CBD isolate), a long-term blood analysis found consistently undetectable levels of THC
Long-term plasma monitoring of THC and CBD in pediatric drug-resistant epilepsy: Implications for cannabidiol therapy with Epidyolex®
In people with cancer, this review of 16 studies suggested that medical cannabis increased survival time, improved cognitive function, mental health, sleep, appetite & pain as well as decreased nausea, vomiting & the use of other medications such as opioids
Impact of Medical Cannabis on the Quality of Life of Cancer Patients: A Critical Review
For anxiety-related disorders from a number of causes, a review on the effects of CBD & THC
Effects of Different Cannabinoid Formulations on Anxiety-Related Disorders, and Tourette Syndrome: A Systematic Review and Meta-Analysis
A review of cannabis for depression, anxiety, PTSD, sleep & cognition
246: Cannabis and Depression, Anxiety, PTSD, Sleep, and Cognitive Function Update and Review
For inflammatory bowel disease, a review on the links between the gut microbiome & the endocannabinoid system
The Intestinal Microbiota: An Environmental Effector for the Endocannabinoid System and Medicinal Cannabis in Inflammatory Bowel Disease
For cats, a review of the studies on the benefits of cannabinoids
Cats and cannabinoids: past, present and future
In a mouse model of obesity, both CBD & THC rich extracts lowered insulin resistance & fatty liver (metabolic dysfunction-associated steatohepatitis (MASH))
Cannabis Improves Metabolic Dysfunction and Macrophage Signatures in Obese Mice
Comments